Company intelligence / Profile preview

Meliapharm

Frankfurt am Main, Hesse, Germany
Ownership
Private
Development stage
Other
01

Overview

MeliaPharm is a German specialty pharmaceutical company headquartered in Frankfurt am Main, specializing in the medical cannabis sector. The company focuses on the procurement, quality assurance, and distribution of pharmaceutical-grade cannabis flowers and cannabinoid extracts. Operating under stringent EU-GMP guidelines, MeliaPharm ensures that its products meet the high standards required for medicinal use in the European market. Their portfolio is designed to support healthcare professionals and pharmacies in providing standardized cannabinoid therapies to patients with chronic and severe conditions. By bridging the gap between international cultivators and local pharmacies, MeliaPharm plays a key role in the German medical cannabis supply chain.

Therapeutic areas
OncologyNeurologyGastroenterology
Modalities
Small moleculePlant-derived extract
Industry
Biotech

Beyond the preview

Go deeper on Meliapharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Meliapharm.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call